The human-specific action of intermedilysin, a homolog of streptolysin O, is dictated by domain 4 of the protein

被引:30
作者
Nagamune, H
Ohkura, K
Sukeno, A
Cowan, G
Mitchell, TJ
Ito, W
Ohnishi, O
Hattori, K
Yamato, M
Hirota, K
Miyake, Y
Maeda, T
Kourai, H
机构
[1] Univ Tokushima, Fac Engn, Dept Biol Sci & Technol, Tokushima 7708506, Japan
[2] Sch Dent, Dept Oral Microbiol, Tokushima 7708503, Japan
[3] Nagoya Univ, Grad Sch Bioagr Sci, Aichi 4648601, Japan
[4] Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland
关键词
intermedilysin; pore-forming toxin; hemolysin; human-specific;
D O I
10.1111/j.1348-0421.2004.tb03479.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intermedilysin is a pore-forming cytolysin belonging to the streptolysin 0 gene family known as the 'Cholesterol-binding/dependent cytolysins' and is unique within the family in that it is highly human-specific. This specificity suggests interaction with a component of human cells other than cholesterol, the proposed receptor for the other toxins of the gene family. Indeed, intermedilysin showed no significant degree of affinity to free or liposome-embedded cholesterol. Characterization of intermedilysin undecapeptide mutants revealed that this lack of affinity to cholesterol was a result of the substitutions of intermedilysin in this region. Absorption assays with erythrocyte membranes from various animals, competitive inhibition with domain 4 of intermedilysin and liposome-binding assays of streptolysin 0 and intermedilysin indicated that cell membrane binding is the human-specific step of intermedilysin action, that the host cell membrane-binding site is located within domain 4 in common with other members of the family and that the receptor for this toxin is not cholesterol. The species specificity of undecapeptide mutants of intermedilysin and streptolysin O and chimeric mutants between intermedilysin and streptolysin O, and intermedilysin and pneumolysin indicated that domain 4 of intermedilysin determines the human-specific action step and the cell-binding site of domain 4 lies within the 56 amino acids of the C-terminal, excluding the undecapeptide region.
引用
收藏
页码:677 / 692
页数:16
相关论文
共 40 条
[11]   Redefining cholesterol's role in the mechanism of the cholesterol's-dependent cytolysins [J].
Giddings, KS ;
Johnson, AE ;
Tweten, RK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) :11315-11320
[12]   Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae [J].
Gilbert, RJC ;
Jiménez, JL ;
Chen, SX ;
Tickle, IJ ;
Rossjohn, J ;
Parker, M ;
Andrew, PW ;
Saibil, HR .
CELL, 1999, 97 (05) :647-655
[13]   SELF-ASSOCIATION OF CHOLESTEROL IN AQUEOUS-SOLUTION [J].
HABERLAND, ME ;
REYNOLDS, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (08) :2313-2316
[14]   Cholesterol-streptolysin O interaction: An EM study of wild-type and mutant streptolysin O [J].
Harris, JR ;
Adrian, M ;
Bhakdi, S ;
Palmer, M .
JOURNAL OF STRUCTURAL BIOLOGY, 1998, 121 (03) :343-355
[15]   Mechanism of membrane insertion of a multimeric β-barrel protein:: Perfringolysin O creates a pore using ordered and coupled conformational changes [J].
Heuck, AP ;
Hotze, EM ;
Tweten, RK ;
Johnson, AE .
MOLECULAR CELL, 2000, 6 (05) :1233-1242
[16]   STUDIES ON MECHANISM OF ACTION OF OXYGEN-LABILE HEMOLYSINS [J].
JOHNSON, MK ;
AULTMAN, KS .
JOURNAL OF GENERAL MICROBIOLOGY, 1977, 101 (AUG) :237-241
[17]  
Korchev YE, 1998, BIOCHEM J, V329, P571
[18]   PROCHECK - A PROGRAM TO CHECK THE STEREOCHEMICAL QUALITY OF PROTEIN STRUCTURES [J].
LASKOWSKI, RA ;
MACARTHUR, MW ;
MOSS, DS ;
THORNTON, JM .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1993, 26 :283-291
[19]   Intermedilysin, a novel cytotoxin specific for human cells, secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess [J].
Nagamune, H ;
Ohnishi, C ;
Katsuura, A ;
Fushitani, K ;
Whiley, RA ;
Tsuji, A ;
Matsuda, Y .
INFECTION AND IMMUNITY, 1996, 64 (08) :3093-3100
[20]  
Nagamune H, 1997, ADV EXP MED BIOL, V418, P773